Clinicians increasingly are recognizing the need to recognize and manage inflammatory bowel disease’s extra-intestinal manifestations. A new Cleveland Clinic review provides guidance.
The presence of inflammatory bowel disease conveys increased risk of comorbid nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and nonalcoholic cirrhosis, two new Cleveland Clinic epidemiological studies show.
Miguel Regueiro, MD, Chair of Cleveland Clinic’s Department of Gastroenterology, Hepatology and Nutrition, highlights six can’t-miss DDW presentations by our researchers.
If you’re looking for the latest insights and leading-edge information on IBD and gastrointestinal endoscopy, you’ll want to attend these upcoming Cleveland Clinic CME events.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Cleveland Clinic colorectal surgeon Amy Lightner, MD, a leading translational researcher and clinical trials director, talks about stem cells’ potential to improve IBD management.
An organotypic model is helping researchers better understand disease processes in ulcerative colitis and colorectal cancer.
Find out how accepting and adjusting psychologically to life with an ileostomy led Coleen Potts to want to help others on their journey as a WOC nurse.
Tumor boards work — so why not an IBD board? A new multidisciplinary IBD Board launched at Cleveland Clinic handles difficult cases and helps patients find much-needed relief.
The largest and longest follow-up study of its kind concludes that, despite reported complications, IPAA remains an excellent option for pediatric patients with UC.
Cleveland Clinic colorectal surgeons are among the nation’s most experienced in reoperative, complex cases. Discover how our team can help your patients.